{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:38:56Z","timestamp":1790836736625,"version":"4.1.0"},"reference-count":91,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T00:00:00Z","timestamp":1375833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic myeloid leukemia (CML) is a hematological malignancy that arises from the transformation of stem hematopoietic cells by the fusion oncogene BCR\/ABL and subsequent clonal expansion of BCR\/ABL-positive progenitor leukemic cells. The BCR\/ABL protein displays a constitutively increased tyrosine kinase activity that alters many regulatory pathways, leading to uncontrolled growth, impaired differentiation and increased resistance to apoptosis featured by leukemic cells. Current CML therapy is based on tyrosine kinase inhibitors (TKIs), primarily imatinib, which induce apoptosis in leukemic cells. However, some patients show primary resistance to TKIs while others develop it in the course of therapy. In both cases, resistance may be underlined by perturbations in apoptotic signaling in leukemic cells. As mitochondria may play an important role in such signaling, alteration in mitochondrial metabolism may change resistance to pro-apoptotic action of TKIs in BCR\/ABL-positive cells. Because BCR\/ABL may induce reactive oxygen species and unfaithful DNA repair, it may affect the stability of mitochondrial DNA, influencing mitochondrial apoptotic signaling and in this way change the sensitivity of CML cells to TKIs. Moreover, cancer cells, including  BCR\/ABL-positive cells, show an increased level of glucose metabolism, resulting from the shift from oxidative phosphorylation to glycolysis to supply ATP for extensive proliferation. Enhanced level of glycolysis may be associated with TKI resistance and requires change in the expression of several genes regulated mostly by hypoxia-inducible factor-1\u03b1, HIF-1\u03b1. Such regulation may be associated with the impaired mitochondrial respiratory system in CML cells. In summary, mitochondria and mitochondria-associated molecules and pathways may be attractive targets to overcome TKI resistance in CML.<\/jats:p>","DOI":"10.3390\/ijms140816348","type":"journal-article","created":{"date-parts":[[2013,8,7]],"date-time":"2013-08-07T11:46:51Z","timestamp":1375876011000},"page":"16348-16364","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR\/ABL-Expressing Cells to Tyrosine  Kinase Inhibitors"],"prefix":"10.3390","volume":"14","author":[{"given":"Sylwester","family":"Glowacki","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection,  University of Lodz, Pomorska 141\/143, Lodz 90-236, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewelina","family":"Synowiec","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection,  University of Lodz, Pomorska 141\/143, Lodz 90-236, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Blasiak","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection,  University of Lodz, Pomorska 141\/143, Lodz 90-236, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2013,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1182\/blood-2008-07-077958","article-title":"Translation of the Philadelphia chromosome into therapy for CML","volume":"112","author":"Druker","year":"2008","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMoa030513","article-title":"Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia","volume":"349","author":"Hughes","year":"2003","journal-title":"N. Engl. J. Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1182\/blood-2006-03-011239","article-title":"Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years","volume":"109","author":"Rousselot","year":"2007","journal-title":"Blood"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1172\/JCI41246","article-title":"Chronic myeloid leukemia: Mechanisms of blastic transformation","volume":"120","author":"Perrotti","year":"2010","journal-title":"J. Clin. Investig"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.18632\/oncotarget.333","article-title":"Chronic myeloid leukemia stem cells in the era of targeted therapies: Resistance, persistence and long-term dormancy","volume":"2","author":"Chomel","year":"2011","journal-title":"Oncotarget"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance","volume":"99","author":"Branford","year":"2002","journal-title":"Blood"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.leu.2404151","article-title":"The Bcr-Abl mutations T315I and Y253H do not confer a growth advantage in the absence of imatinib","volume":"20","author":"Miething","year":"2006","journal-title":"Leukemia"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"7374","DOI":"10.1158\/1078-0432.CCR-06-1516","article-title":"GIMEMA working party on chronic myeloid leukemia contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: By the GIMEMA working party on chronic myeloid leukemia","volume":"12","author":"Soverini","year":"2006","journal-title":"Clin. Cancer Res"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","article-title":"Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia","volume":"7","author":"Weisberg","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbapap.2005.07.040","article-title":"Advances in the structural biology, design and clinical development of Bcr-Abl kinase inhibitors for the treatment of chronic myeloid leukaemia","volume":"1754","author":"Manley","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1038\/sj.bjc.6603170","article-title":"AMN107 (nilotinib): A novel and selective inhibitor of BCR-ABL","volume":"94","author":"Weisberg","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_15","first-page":"115","article-title":"Bosutinib in the management of chronic myelogenous leukemia","volume":"7","author":"Amsberg","year":"2013","journal-title":"Biologics"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Press, R.D., Kamel-Reid, S., and Ang, D. (2013). BCR-ABL1 RT-qPCR for monitoring the molecular response to tyrosine kinase inhibitors in chronic myeloid leukemia. J. Mol. Diagn.","DOI":"10.1016\/j.jmoldx.2013.04.007"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(07)70342-X","article-title":"Part I: Mechanisms of resistance to imatinib in chronic myeloid leukaemia","volume":"8","author":"Apperley","year":"2007","journal-title":"Lancet Oncol"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1182\/blood.V101.6.2368","article-title":"MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models","volume":"101","author":"Mahon","year":"2003","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1038\/sj.leu.2404318","article-title":"Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate","volume":"20","author":"Jabbour","year":"2006","journal-title":"Leukemia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1182\/blood-2003-02-0562","article-title":"Involvement of reactive oxygen species in adaphostin-induced cytotoxicity in human leukemia cells","volume":"102","author":"Chandra","year":"2003","journal-title":"Blood"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1182\/blood-2005-07-2966","article-title":"Adaphostin-induced oxidative stress overcomes BCR\/ABL mutation-dependent and -independent imatinib resistance","volume":"107","author":"Chandra","year":"2006","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/leu.2008.74","article-title":"Effective killing of Gleevec-resistant CML cells with T315I mutation by a natural compound PEITC through redox-mediated mechanism","volume":"22","author":"Zhang","year":"2008","journal-title":"Leukemia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"Sattler","year":"2000","journal-title":"J. Biol. Chem"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1182\/blood-2004-03-0849","article-title":"Activation of the PI3K\/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood-2005-07-2815","article-title":"BCR\/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance","volume":"108","author":"Koptyra","year":"2006","journal-title":"Blood"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.freeradbiomed.2009.12.022","article-title":"Reactive oxygen species, cellular redox systems, and apoptosis","volume":"48","author":"Circu","year":"2010","journal-title":"Free Radic. Biol. Med"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s11010-007-9520-8","article-title":"Mitochondria: A hub of redox activities and cellular distress control","volume":"305","author":"Kakkar","year":"2007","journal-title":"Mol. Cell. Biochem"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/1357-2725(95)00025-K","article-title":"Oxidative damage to mitochondrial DNA and its relationship to ageing","volume":"27","author":"Richter","year":"1995","journal-title":"Int. J. Biochem. Cell Biol"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM198501173120305","article-title":"Oxygen-derived free radicals in postischemic tissue injury","volume":"312","author":"McCord","year":"1985","journal-title":"N. Engl. J. Med"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/biof.5520070303","article-title":"Mitochondrial biology, degenerative diseases and aging","volume":"7","author":"Wallace","year":"1998","journal-title":"Biofactors"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00763099","article-title":"Molecular basis of mitochondrial DNA disease","volume":"26","author":"Brown","year":"1994","journal-title":"J. Bioenerg. Biomembr"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0014-5793(96)00988-X","article-title":"Mitochondria and programmed cell death: Back to the future","volume":"396","author":"Petit","year":"1996","journal-title":"FEBS Lett"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/emboj.2008.15","article-title":"DNA-damage repair; the good, the bad, and the ugly","volume":"27","author":"Hakem","year":"2008","journal-title":"EMBO J"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/jmg.32.8.654","article-title":"Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness","volume":"32","author":"Manouvrier","year":"1995","journal-title":"J. Med. Genet"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ng0892-368","article-title":"Mutation in mitochondrial tRNALeu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness","volume":"1","author":"Lemkes","year":"1992","journal-title":"Nat. Genet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/348651a0","article-title":"A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies","volume":"348","author":"Goto","year":"1990","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2353\/jmoldx.2006.050066","article-title":"Detection of common disease-causing mutations in mitochondrial DNA (mitochondrial encephalomyopathy, lactic acidosis with stroke-like episodes MTTL1 3243 A>G and myoclonic epilepsy associated with ragged-red fibers MTTK 8344 A>G) by real-time polymerase chain reaction","volume":"8","author":"Fan","year":"2006","journal-title":"J. Mol. Diagn"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/humu.20338","article-title":"m.6267G>A: A recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors","volume":"27","author":"Gallardo","year":"2006","journal-title":"Hum. Mutat."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1073\/pnas.0408894102","article-title":"mtDNA mutations increase tumorigenicity in prostate cancer","volume":"102","author":"Petros","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/jmg.2006.048553","article-title":"Stability of the m.8993T\u2192G mtDNA mutation load during human embryofetal development has implications for the feasibility of prenatal diagnosis in NARP syndrome","volume":"44","author":"Steffann","year":"2007","journal-title":"J. Med. Genet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0921-8777(99)00028-2","article-title":"Mitochondrial mutagenesis in human cells and tissues","volume":"434","author":"Marcelino","year":"1999","journal-title":"Mutat. Res"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.lfs.2011.05.010","article-title":"Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers","volume":"89","author":"Yu","year":"2011","journal-title":"Life Sci"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1182\/blood-2008-05-157974","article-title":"A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma","volume":"112","author":"Lan","year":"2008","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.exger.2010.01.017","article-title":"Mitochondrial DNA repair and association with aging\u2014An update","volume":"45","author":"Gredilla","year":"2010","journal-title":"Exp. Gerontol"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/bbrc.2001.5156","article-title":"Mitochondria isolated from liver contain the essential factors required for RNA\/DNA oligonucleotide-targeted gene repair","volume":"285","author":"Chen","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.dnarep.2009.01.021","article-title":"Novel DNA mismatch-repair activity involving YB-1 in human mitochondria","volume":"8","author":"Mason","year":"2009","journal-title":"DNA Repair"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/ijms14022996","article-title":"Mitochondrial and nuclear DNA damage and repair in age-related macular degeneration","volume":"14","author":"Blasiak","year":"2013","journal-title":"Int. J. Mol. Sci"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0891-5849(02)00787-6","article-title":"Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells","volume":"32","author":"Bohr","year":"2002","journal-title":"Free Radic. Biol. Med"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1128\/MCB.00457-08","article-title":"Removal of oxidative DNA damage via FEN1-dependent long-patch base excision repair in human cell mitochondria","volume":"28","author":"Liu","year":"2008","journal-title":"Mol. Cell. Biol"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/01.RES.86.9.960","article-title":"Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells","volume":"86","author":"Ballinger","year":"2000","journal-title":"Circ. Res"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: Controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol. Rev"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbamcr.2010.08.002","article-title":"Apoptogenic factors released from mitochondria","volume":"1813","author":"Vaux","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.molcel.2008.02.012","article-title":"Quantitative analysis of pathways controlling extrinsic apoptosis in single cells","volume":"30","author":"Albeck","year":"2008","journal-title":"Mol. Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ccr.2008.11.001","article-title":"Transient potent BCR-ABL inhibition is sufficient to commit chronic myeloid leukemia cells irreversibly to apoptosis","volume":"14","author":"Shah","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cbi.2005.03.002","article-title":"Imatinib (STI571) induces DNA damage in BCR\/ABL-expressing leukemic cells but not in normal lymphocytes","volume":"152","author":"Czechowska","year":"2005","journal-title":"Chem. Biol. Interact"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s10495-007-0746-4","article-title":"Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes","volume":"12","author":"Leber","year":"2007","journal-title":"Apoptosis"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.mam.2010.02.008","article-title":"The causes of cancer revisited: \u201cMitochondrial malignancy\u201d and ROS-induced oncogenic transformation\u2014Why mitochondria are targets for cancer therapy","volume":"31","author":"Ralph","year":"2010","journal-title":"Mol. Aspects Med"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1083\/jcb.200512100","article-title":"Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism","volume":"175","author":"Pelicano","year":"2006","journal-title":"J. Cell Biol"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ccr.2007.07.006","article-title":"HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation","volume":"12","author":"Gordan","year":"2007","journal-title":"Cancer Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/(SICI)1098-2264(199602)15:2<95::AID-GCC3>3.0.CO;2-Z","article-title":"Novel mitochondrial DNA deletion found in a renal cell carcinoma","volume":"15","author":"Horton","year":"1996","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0959-8049(98)00360-8","article-title":"Comments on: Mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Tamura, et al","volume":"35","author":"Soares","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mito.2008.07.006","article-title":"Reversible regulation of metastasis by ROS-generating mtDNA mutations","volume":"8","author":"Ishikawa","year":"2008","journal-title":"Mitochondrion"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj3480425","article-title":"Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells","volume":"348","author":"Lee","year":"2000","journal-title":"Biochem. J"},{"key":"ref_67","first-page":"962","article-title":"Multifactorial nature of high frequency of mitochondrial DNA mutations in somatic mammalian cells","volume":"74","author":"Todorov","year":"2009","journal-title":"Biochemistry"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Carew, J.S., and Huang, P. (2002). Mitochondrial defects in cancer. Mol. Cancer, 1.","DOI":"10.1186\/1476-4598-1-9"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/sj.leu.2403043","article-title":"Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: Clinical significance and therapeutic implications","volume":"17","author":"Carew","year":"2003","journal-title":"Leukemia"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/ejh.12090","article-title":"Characterization and prognostic significance of mitochondrial DNA variations in acute myeloid leukemia","volume":"90","author":"Silkjaer","year":"2013","journal-title":"Eur. J. Haematol"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1073\/pnas.62.4.1077","article-title":"Complex mitochondrial DNA in leukemic and normal human myeloid cells","volume":"62","author":"Clayton","year":"1969","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1073\/pnas.061038798","article-title":"Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddp069","article-title":"A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis","volume":"18","author":"Park","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.freeradbiomed.2013.04.002","article-title":"Mitochondrial genome depletion in human liver cells abolishes bile acid-induced apoptosis: Role of the Akt\/mTOR survival pathway and Bcl-2 family proteins","volume":"61","author":"Marin","year":"2013","journal-title":"Free Radic. Biol. Med"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","volume":"119","author":"Kopinski","year":"2012","journal-title":"Blood"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood.V91.5.1700","article-title":"Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3","volume":"91","author":"Liu","year":"1998","journal-title":"Blood"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1182\/blood-2009-05-219550","article-title":"BMS-214662 induces mitochondrial apoptosis in chronic myeloid leukemia (CML) stem\/progenitor cells, including CD34+38\u2212 cells, through activation of protein kinase Cbeta","volume":"114","author":"Pellicano","year":"2009","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s10495-010-0457-0","article-title":"Enhancement of imatinib-induced apoptosis of BCR\/ABL-expressing cells by nutlin-3 through synergistic activation of the mitochondrial apoptotic pathway","volume":"15","author":"Kurosu","year":"2010","journal-title":"Apoptosis"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-08-2978","article-title":"Sorafenib induces apoptosis specifically in cells expressing BCR\/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway","volume":"69","author":"Kurosu","year":"2009","journal-title":"Cancer Res"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1158\/1078-0432.CCR-08-3291","article-title":"Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells","volume":"15","author":"Kominsky","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"39337","DOI":"10.1074\/jbc.M305689200","article-title":"Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface","volume":"278","author":"Bentley","year":"2003","journal-title":"J. Biol. Chem"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1038\/sj.onc.1208461","article-title":"Chronic myeloid leukaemia: An investigation into the role of Bcr-Abl-induced abnormalities in glucose transport regulation","volume":"24","author":"Barnes","year":"2005","journal-title":"Oncogene"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"37747","DOI":"10.1074\/jbc.M105796200","article-title":"Gleevec (STI571) influences metabolic enzyme activities and glucose carbon flow toward nucleic acid and fatty acid synthesis in myeloid tumor cells","volume":"276","author":"Boren","year":"2001","journal-title":"J. Biol. Chem"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.1158\/1078-0432.CCR-04-0039","article-title":"Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells","volume":"10","author":"Gottschalk","year":"2004","journal-title":"Clin. Cancer Res"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.bjc.6604946","article-title":"Time-dependent effects of imatinib in human leukaemia cells: A kinetic NMR-profiling study","volume":"100","author":"Klawitter","year":"2009","journal-title":"Br. J. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e21924","DOI":"10.1371\/journal.pone.0021924","article-title":"Exploiting mitochondrial dysfunction for effective elimination of imatinib-resistant leukemic cells","volume":"6","author":"Kluza","year":"2011","journal-title":"PLoS One"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1038\/onc.2010.67","article-title":"Imatinib resistance associated with BCR-ABL upregulation is dependent on HIF-1alpha-induced metabolic reprograming","volume":"29","author":"Zhao","year":"2010","journal-title":"Oncogene"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"8066","DOI":"10.1158\/0008-5472.CAN-10-0608","article-title":"Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl","volume":"70","author":"Mason","year":"2010","journal-title":"Cancer Res"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/8\/16348\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:48:29Z","timestamp":1760219309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/8\/16348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,7]]},"references-count":91,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8]]}},"alternative-id":["ijms140816348"],"URL":"https:\/\/doi.org\/10.3390\/ijms140816348","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,7]]}}}